Propanc Biopharma, a Nasdaq-listed biotech firm, has secured up to $100 million to bolster its digital asset strategy. Post navigation Interview | TradFi doesn’t see the potential of stablecoins: Mega MatrixSenators introduce bill to move crypto market regulation from SEC to CFTC
